These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9486497)
21. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome. Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820 [TBL] [Abstract][Full Text] [Related]
22. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [TBL] [Abstract][Full Text] [Related]
23. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738 [TBL] [Abstract][Full Text] [Related]
24. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts. Behringer D; Bertz H; Schmoor C; Berger C; Dwenger A; Finke J Bone Marrow Transplant; 1999 Aug; 24(3):295-302. PubMed ID: 10455369 [TBL] [Abstract][Full Text] [Related]
25. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
27. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients. Kasow KA; Sims-Poston L; Eldridge P; Hale GA Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921 [TBL] [Abstract][Full Text] [Related]
28. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran. Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149 [TBL] [Abstract][Full Text] [Related]
30. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation. Cornelissen JJ; Fibbe WE; Schattenberg AV; Petersen EJ; Willemze R; de Witte TJ; Löwenberg B; Verdonck LF; vd Biezen A; Brand R Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S66-70. PubMed ID: 9712499 [TBL] [Abstract][Full Text] [Related]
31. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547 [TBL] [Abstract][Full Text] [Related]
32. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia. Madero L; Díaz MA; Ortega JJ; Olive T; Martínez A; Badell I; Muñoz A; Gómez P Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411 [TBL] [Abstract][Full Text] [Related]
33. Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution. de la Rubia J; Cantero S; Sanz GF; Remigia MJ; Monteagudo E; Moscardó F; Martín G; Lorenzo I; Jiménez C; Martínez J; Montesinos P; Jarque I; Sanz MA Bone Marrow Transplant; 2005 Aug; 36(4):325-9. PubMed ID: 15968276 [TBL] [Abstract][Full Text] [Related]
34. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold? Singhal S; Powles R; Treleaven J; Kulkarni S; Sirohi B; Horton C; Millar B; Shepherd V; Tait D; Saso R; Rowland A; Long S; Mehta J Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837 [TBL] [Abstract][Full Text] [Related]
35. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
36. Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias. Bunin N; Aplenc R; Grupp S; Pierson G; Monos D Bone Marrow Transplant; 2006 Jan; 37(2):143-9. PubMed ID: 16284615 [TBL] [Abstract][Full Text] [Related]
37. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia. Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schauenstein K; Schumm M; Handgretinger R Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628 [TBL] [Abstract][Full Text] [Related]
38. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714 [TBL] [Abstract][Full Text] [Related]
39. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487 [TBL] [Abstract][Full Text] [Related]
40. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft. Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]